Page last updated: 2024-10-27

flufenamic acid and Hepatocellular Carcinoma

flufenamic acid has been researched along with Hepatocellular Carcinoma in 3 studies

Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.

Research Excerpts

ExcerptRelevanceReference
"In rat hepatocytes and HTC hepatoma cells, increases in cell volume stimulate ATP release, and the localized increase in extracellular ATP increases membrane Cl(-) permeability and stimulates cell volume recovery through activation of P(2) receptors."1.30Evidence for Gd(3+) inhibition of membrane ATP permeability and purinergic signaling. ( Davison, AK; Feranchak, AP; Fitz, JG; Roman, RM; Schwiebert, EM, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Li, ZY1
Yin, YF1
Guo, Y1
Li, H1
Xu, MQ1
Liu, M1
Wang, JR1
Feng, ZH1
Duan, XC1
Zhang, S1
Zhang, SQ1
Wang, GX1
Liao, A1
Wang, SM1
Zhang, X1
Roman, RM1
Feranchak, AP1
Davison, AK1
Schwiebert, EM1
Fitz, JG1
Davidova, SY1
Shapot, VS1
Drozdova, GA1

Other Studies

3 other studies available for flufenamic acid and Hepatocellular Carcinoma

ArticleYear
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: 20-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Animals; Anti-Inflammatory

2020
Evidence for Gd(3+) inhibition of membrane ATP permeability and purinergic signaling.
    The American journal of physiology, 1999, Volume: 277, Issue:6

    Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal;

1999
On the heterogeneity of catalase in rat liver and experimental hepatomas of rats and mice.
    Biochimica et biophysica acta, 1970, Nov-11, Volume: 220, Issue:2

    Topics: Alcohols; Animals; Bile Acids and Salts; Carcinoma, Hepatocellular; Catalase; Cell Membrane; Female;

1970